An Open-label Study to Investigate P2X7 Receptor Occupancy by JNJ-54175446 With the Newly Developed P2X7 Receptor PET Tracer 18F-JNJ-64413739
Phase of Trial: Phase I
Latest Information Update: 03 Aug 2017
At a glance
- Drugs JNJ 54175446 (Primary) ; 18F-JNJ-64413739
- Indications Major depressive disorder
- Focus Diagnostic use; Pharmacokinetics
- Sponsors Janssen-Cilag
- 28 Jul 2017 Planned End Date changed from 14 Jul 2018 to 25 Apr 2018.
- 28 Jul 2017 Planned primary completion date changed from 14 Jul 2018 to 25 Apr 2018.
- 14 Apr 2017 Status changed from not yet recruiting to recruiting.